The real risk isn't in running robust tests; it’s in wasting money or cutting high-performing channels based on misleading ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with ...

A large Dutch randomized clinical trial (SUMMER) found that a widely marketed antioxidant supplement (Impryl) did not improve ...

Conducted across seven U.S. health systems including Duke University Health System, Cleveland Clinic, and Ascension St. Vincent, VITAL-HF enrolled 178 adults with HFrEF who were not yet optimized on ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for ...

A total of 295 eligible patients were enrolled with a median follow-up of 5.0 years. The arms were well balanced, with a median age of 65 years (IQR 59-71), 50% with positive surgical margins, 51% ...

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...

The effect of chronic breathlessness on the lives of patients and their loved ones is tremendous, regardless of the ...

Med Safety, a free smartphone app, has boosted healthcare workers’ reporting of adverse drug reactions in Uganda.

Nerandomilast is both effective and well-tolerated, representing a "major step forward for the treatment of progressive pulmonary fibrosis (PPF)," with its effect on clinical outcomes sustained over ...